420 with CNW — Genetic Testing May Help Transform the Marijuana Sector
Recent research conducted by CSO and president of EVIO Labs Inc. (OTC: EVIO) Anthony Smith and M.J. Murdock Metabolomics Lab director Bernd Markus Lange, together with their colleagues, may be useful to marijuana consumers, producers and breeders. The researchers examined various data sets to differentiate marijuana strains. Each strain of marijuana contains different concentrations of cannabinoids, including CBD, which is nonpsychoactive, and THC, which is psychoactive. This allows consumers to choose marijuana based on desired effects, such as particular aromas and relaxation. However, the genetic information that makes up these differences isn’t well understood. This is why the researchers’ discoveries…